Slingshot members are tracking this event:
Lilly (LLY) and Boehringer Ingelheim's Glyxambi Recommended for Approval by European Ad Comm for Type 2 Diabetes
Slingshot Insights Explained
Sep 16, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Glyxambi, European Medicines Agency, Chmp, Type 2 Diabetes